Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro does not list cold hands or cold feet as a recognised side effect in its licensed product information, and most people who notice this symptom are experiencing something unrelated to the medicine itself. That said, a real mechanism exists that is worth understanding — and a small number of people on tirzepatide do report temperature changes in their extremities, often tied to the significant weight loss the treatment produces. If cold hands and feet appear suddenly, are severe, or come with other symptoms, a clinician should be the first call. These are prescription-only medicines assessed individually; a prescriber decides whether Mounjaro is appropriate for you and can review any new symptoms during treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A common assumption is that because tirzepatide affects so many body systems, any new symptom must be caused by it. Cold hands are a good example of where that thinking leads people astray. The NHS patient information for tirzepatide covers the medicine's known side effects in plain language, and cold extremities do not appear. The Mounjaro SmPC (the authoritative licensed product document) does not list peripheral coldness either. That does not mean every person's experience is wrong; it means the pharmacological evidence for a direct causal link is thin, and other explanations are more likely.
What people on Mounjaro often notice is that the cold feeling tends to start or worsen after meaningful weight loss begins, rather than immediately after the first injection. That timing clue is important.
Worth knowing: symptoms like tingling or numbness in the hands and feet are a separate question. If that's what you're experiencing, our page on Mounjaro tingling in the hands and feet covers the relevant clinical picture in more detail.
Adipose tissue (body fat) does more than store energy. It acts as insulation, particularly around the extremities. When someone loses a substantial amount of weight relatively quickly, that insulating layer becomes thinner, and hands and feet are the first places many people notice it. The body also diverts blood to core organs when it senses cooling, so peripheral circulation can feel reduced even when nothing pathological is happening.
There is a second mechanism: calorie restriction, which tirzepatide promotes through appetite suppression, can modestly reduce basal metabolic rate. A slower metabolic rate means slightly less heat generated. Together, less insulation and slightly less heat output is a plausible explanation for why some people on tirzepatide find themselves reaching for an extra layer.
This is not unique to Mounjaro. It has been noted informally with other weight-loss treatments and is a well-recognised phenomenon after bariatric surgery. The NHS England guidance on weight management injections encourages patients to discuss any new or persistent symptoms with their prescribing team, which is the right approach here too.
If you're weighing up the broader cost and practicalities of treatment, our treatment overview page covers what to expect from start to finish.
Most people describing Mounjaro cold hands are describing a bilateral, mild feeling that improves when they warm up or move around. That pattern is consistent with the weight-loss mechanism above and typically does not need urgent attention beyond mentioning it at your next prescriber review.
A different picture needs faster assessment. Seek medical advice promptly if the coldness is one-sided, if one hand or foot looks pale, blue or mottled compared to the other, if sensation is lost, or if the symptom came on suddenly rather than gradually. Those features can indicate a circulatory problem that has nothing to do with Mounjaro — and that coincides with the period you happen to be on it. Raynaud's phenomenon, anaemia, and thyroid changes can all present with cold extremities and are worth ruling out with a GP.
Our clinical team can also review any symptoms that worry you; you can read more about how we work on the about us page. For questions specific to cold feet on Mounjaro, that page goes into comparable detail on the feet-specific side of the picture.
Practically speaking, most people find simple measures help: layering up, keeping active during the day to maintain circulation, and staying well hydrated. Dehydration (which can happen if nausea leads to reduced fluid intake) can itself worsen peripheral coldness, so it is worth addressing GI side effects early with your prescriber rather than tolerating them.
If you are also noticing unusual changes to your hair during treatment, that is another weight-loss-related effect covered separately; our page on hair changes after Mounjaro addresses the timeline and what to expect. Both symptoms share the same root cause: the body adapting to significant, relatively rapid weight change.
Above all, do not stop or adjust your dose because of cold hands without speaking to your prescriber first. Dose decisions belong with the clinician who holds your full medical picture. If you have not yet started treatment and are researching what to expect, our prescribers are happy to discuss symptoms, suitability and the process during a free consultation, speak to our prescribers here.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.